Sharad A Ghamande

Department Chair

  • 860 Citations
  • 16 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 860 Citations
  • 16 h-Index
  • 33 Article
  • 2 Letter

A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer

Mysona, D., Pyrzak, A., Purohit, S., Zhi, W., Sharma, A., Tran, L., Tran, P., Bai, S., Rungruang, B., Ghamande, S. & She, J. X., Mar 2019, In : Gynecologic Oncology. 152, 3, p. 574-580 7 p.

Research output: Contribution to journalArticle

  • 2 Scopus citations

    Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

    Falchook, G., Coleman, R. L., Roszak, A., Behbakht, K., Matulonis, U., Ray-Coquard, I., Sawrycki, P., Duska, L. R., Tew, W., Ghamande, S. A., Lesoin, A., Schwartz, P. E., Buscema, J., Fabbro, M., Lortholary, A., Goff, B., Kurzrock, R., Martin, L. P., Gray, H. J., Fu, S. & 6 others, Sheldon-Waniga, E., Lin, H. M., Venkatakrishnan, K., Zhou, X., Leonard, E. J. & Schilder, R. J., Jan 2019, In : JAMA Oncology. 5, 1

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Bovine Pericardial Graft for Second-Trimester Cesarean Scar Dehiscence

    Stephens, A., Patel, K., Davis, J. & Ghamande, S., Feb 1 2019, In : Obstetrics and gynecology. 133, 2, p. 364-367 4 p.

    Research output: Contribution to journalArticle

  • Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

    Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In : Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

    Research output: Contribution to journalArticle

  • 16 Scopus citations